# Sclerostin and Vascular Calcification in CKD and Renal Transplant

> **NCT04066855** · — · UNKNOWN · sponsor: **Ahmed Faisal Mohamed Mohamed Saleh** · enrollment: 36 (estimated)

## Conditions studied

- Vascular Calcification
- Chronic Kidney Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04066855
- **Lead sponsor:** Ahmed Faisal Mohamed Mohamed Saleh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2020-08
- **Final completion:** 2020-09
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2019-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066855, "Sclerostin and Vascular Calcification in CKD and Renal Transplant". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04066855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*